News

Roots of Acute Worsening in ILD Elusive

Publish date: November 28, 2011

 

EXPERT ANALYSIS FROM THE ANNUAL MEETING OF THE AMERICAN COLLEGE OF CHEST PHYSICIANS

Dr. Collard disclosed that he receives research funding from the National Institutes of Health, the University of California, Boehringer Ingelheim, and Genentech. He also receives consulting fees from Fibrogen, Gilead, InterMune, and Onyx.

Pages

Recommended Reading

A Win for Big Tobacco
MDedge Internal Medicine
Steroids May Help if Given Early in ALI-ARDS
MDedge Internal Medicine
Most Smokers Want to Quit; Few Get Help
MDedge Internal Medicine
Fostering Meaningful Communication at Life's End
MDedge Internal Medicine
Criteria Shift for Lung Transplantation Candidacy
MDedge Internal Medicine
Overweight Patients Don't Have Higher Risk of Death After Surgery
MDedge Internal Medicine
Long-Term Impairments Common in ALI/ARDS
MDedge Internal Medicine
Discussing End-of-Life Planning with Patients
MDedge Internal Medicine
FDA Approves Low-Dose Zolpidem for Night Awakening
MDedge Internal Medicine
Beta2 Agonists for Asthma in Pregnancy
MDedge Internal Medicine